NEW: Examine Personalized — easily keep up with the latest research. On sale until tonight! Learn more

Studies related to Depression and Phenylpiracetam

The Phenotropil Treatment Of The Consequences Of Brain Organic Lesions

Effect Decrease
Trial Design Cohort
Trial Length 2-4 Weeks
Number of Subjects 99
Sex Both Genders
Age Range 45-64
Notes for this study:
In persons with encephalopathy following gliomas or acute
lesions (of organic origin) given 200mg phenylpiracetam once daily noted improvements in depression (38+/-4%), anxiety (50+/-5%), and cognitive decline as assessed by the MMSE (45+/-6%) when compared to baseline. No control group was used in this open-label study.